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Trauma and post-traumatic stress disorder: children should 
be seen and heard
Experiencing trauma in childhood and adolescence—
crucial periods for our developing brains and 
self-identity—has long been recognised as a risk 
factor for the development of psychopathology. In 
The Lancet Psychiatry, Stephanie Lewis and colleagues1 
present data from a twin-cohort study in England and 
Wales, the Environmental Risk study, with measures of 
trauma, psychopathology (including post-traumatic 
stress disorder [PTSD]), risk behaviours, and clinical 
service use. One of the many strengths of this study 
is the high rates of participation at follow-up. The 
research team should be lauded for their endeavour: 
this study is influential research that is of immediate 
value to clinicians and policy makers. Similar studies 
are now needed in other countries alongside validation 
of the risk calculator in independent cohorts.
A key finding from Lewis and colleagues’ sample1 
is that almost a third of children were exposed to 
trauma, either directly or vicariously, within the range 
of internationally previously reported prevalence.2,3 This 
finding indicates the need to determine the population 
level interventions capable of preventing trauma. 
Notably, and in keeping with the adult literature,4 of 
traumatised children who go on to develop PTSD, 
the highest risk index trauma was of an interpersonal 
nature—ie, child maltreatment—reported in nearly half 
of the participants with PTSD. Clinicians and researchers 
must also establish whether interventions targeting risk 
factors1,3 and resilience factors5 for PTSD are beneficial, 
such that when a child is victimised the likelihood 
of developing psychopathology can be reduced. Since 
the response of significant others, including family 
members, to a child’s disclosure of trauma affects the 
child’s subsequent risk of psychopathology,6 a further 
target could be to increase social support and enable 
adults to respond to trauma disclosures in such a way 
that reduces stigmatisation, shame, and guilt.  At 
a cognitive level, these interpersonal processes are 
thought to influence the manifestation of a con-
stellation of negative beliefs about the self associ ated 
with shame, including, for example, “It was my fault”, 
“I’m a bad person”, and “I am defect ive”. Together 
these negative self-schemata predict the subsequent 
development of more complicated psychopathology7 
and self-injury.8
As found in Lewis and colleagues’ study,1 trauma 
is not necessarily equivalent to PTSD. The trauma 
can be potentially associated with illnesses other 
than PTSD, capable of causing a trail of anguish in its 
wake. Trauma survivors had high rates of all measured 
adverse mental health outcomes, with odds ratios 
greatest for drug dependence (3·52, 95% CI 1·36–9·12) 
and psychotic symptoms (2·64, 1·38–5·04). Given the 
potentially complex nature of mental health problems 
experienced by childhood trauma survivors alongside 
poor prognosis and high readmission rates, this 
population would likely benefit from expert psychiatric 
trauma services.
From a global perspective, there is growing 
divergence between the ICD and DSM criteria for 
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PTSD. The ICD-11 will focus on core symptoms 
(re-experiencing, avoidance, and persistent threat) 
whereas DSM-5 includes additional combinations of 
symptoms.9 From a neurobiological perspective, these 
constructs are unlikely to be equivalent. Clinicians 
using the ICD should therefore be careful when 
applying the research literature using DSM-5 criteria 
to their own practice and vice versa.9 Furthermore, 
childhood trauma exposure is a significant risk factor 
for the ICD-11 diagnosis of complex PTSD and there is 
a scarcity of published research for this new diagnosis. 
This is important clinically, as much of the evidence for 
PTSD treatments is based on single event adult trauma, 
rather than multiple event traumas during childhood 
and adolescence, which are thought to be associated 
with complex PTSD.
Recent progress has been made in the understanding 
of the effects of childhood maltreatment on the brain.10 
The challenge for neuroscience is to understand the 
specific mechanisms through which developmental 
trauma can alter neurocognitive systems to induce 
latent vulnerability to mental illness so that these can 
be targeted therapeutically.11 Candidate target circuits 
include memory processing and the dopaminergic 
system. Urgent research is needed to understand these 
underlying mechanisms—both in young people and in 
adults.
As is the case in many countries, a further important 
finding from Lewis and colleagues’ study1 is the 
huge unmet clinical need for most trauma survivors 
in England and Wales. Unfortunately, it is probable 
that undiagnosed PTSD follows most young people 
into adulthood—even in those using secondary care 
psychiatric services.12 Lewis and colleagues propose a 
new screening tool to address this problem. Although 
further research is needed to show the use of such 
an approach, any screening is only ever to going be 
effective if appropriate treatment is available. The 
relentless under-resourcing of psychiatric services, 
and particularly Child and Adolescent Mental Health 
services, in England is a national disgrace and as such 
currently precludes the rollout of any imaginable future 
screening programme. For most trauma survivors who 
are not able to access assessment and treatment, the 
internalised meaning communicated by this societal 
neglect is likely to be one that perpetuates victimhood 
and worsens outcome. Policy makers would therefore be 
wise to be compassionate and improve the provision of 
health care for all survivors of childhood and adolescent 
trauma.
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